Literature DB >> 3314529

Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients.

H K Müller-Hermelink1, G E Sale, B Borisch, R Storb.   

Abstract

A major hypothesis to explain the immunodeficiency associated with bone marrow transplantation states that thymic epithelial damage due to graft-versus-host disease (GVHD) abrogates or delays the recovery of normal immunologic function. This study evaluated the thymus glands of 36 human bone marrow transplant recipients dying between 4 and 1742 days after transplant using histology, histochemistry, and immunohistology. The observations lead to a model of thymic damage by irradiation, chemotherapy, and GVHD in which early injury by all three of these agents results in profound thymic atrophy followed by long-delayed restitution. Patients undergoing total body irradiation showed more severe damage to thymic cortical and medullary epithelium than did patients undergoing chemotherapy alone as preparation for transplantation. Patients with GVHD showed additional damage in the form of individual thymic epithelial cell death and showed HLA-DR surface protein expression on thymic epithelium during GVHD. Longer-term survivors showed a profoundly delayed restitution of normal thymic epithelium and delayed evidence of restored lymphopoiesis. A few patients dying late after transplant showed evidence of reconstitution of normal thymic structure or nodules of lymphopoiesis in focal areas of epithelial-cell reconstitution. Evidence of such lymphopoiesis was seen at times ranging between 90 and 1742 days after grafting. The data are consistent with a model of long-standing thymic damage caused by GVHD which is reversible after the development of tolerance.

Entities:  

Mesh:

Year:  1987        PMID: 3314529      PMCID: PMC1899731     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  The graft-versus-host reaction and immune function. II. Recruitment of pre-T-cells in vivo by graft-versus-host-induced dysplastic thymuses following irradiation and bone marrow treatment.

Authors:  M Seddik; T A Seemayer; W S Lapp
Journal:  Transplantation       Date:  1984-03       Impact factor: 4.939

Review 2.  Immunologic reconstitution after human marrow grafting.

Authors:  R P Witherspoon; L G Lum; R Storb
Journal:  Semin Hematol       Date:  1984-01       Impact factor: 3.851

3.  T cell regeneration after allogeneic and autologous bone marrow transplantation.

Authors:  D C Linch; L J Knott; R M Thomas; P Harper; A H Goldstone; E G Davis; R J Levinski
Journal:  Br J Haematol       Date:  1983-03       Impact factor: 6.998

Review 4.  Allogenic bone marrow transplantation: current status and future directions.

Authors:  R J O'Reilly
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

5.  T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: imbalances of T-cell subpopulations having unique regulatory and cognitive functions.

Authors:  W Friedrich; R J O'Reilly; B Koziner; D F Gebhard; R A Good; R L Evans
Journal:  Blood       Date:  1982-04       Impact factor: 22.113

6.  Low serum thymic hormone levels in patients with chronic graft-versus-host disease.

Authors:  K Atkinson; G S Incefy; R Storb; K M Sullivan; T Iwata; M Dardenne; H D Ochs; R A Good; E D Thomas
Journal:  Blood       Date:  1982-05       Impact factor: 22.113

7.  Recovery of in vivo cellular immunity after human marrow grafting. Influence of time postgrafting and acute graft-versus-host disease.

Authors:  R P Witherspoon; D Matthews; R Storb; K Atkinson; M Cheever; H J Deeg; K Doney; J Kalbfleisch; D Noel; R Prentice
Journal:  Transplantation       Date:  1984-02       Impact factor: 4.939

8.  Demonstration of abnormalities in expression of thymic epithelial surface antigens in severe cellular immunodeficiency diseases.

Authors:  B F Haynes; R W Warren; R H Buckley; J E McClure; A L Goldstein; F W Henderson; L L Hensley; G S Eisenbarth
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

9.  Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.

Authors:  G W Santos; P J Tutschka; R Brookmeyer; R Saral; W E Beschorner; W B Bias; H G Braine; W H Burns; G J Elfenbein; H Kaizer
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

10.  T cell regeneration after allogeneic bone marrow transplantation.

Authors:  M Favrot; G Janossy; N Tidman; H Blacklock; E Lopez; M Bofill; I Lampert; G Morgenstein; R Powles; H G Prentice
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

View more
  17 in total

1.  CD34+-selected autologous peripheral blood stem cell transplantation conditioned with total body irradiation for malignant lymphoma: increased risk of infectious complications.

Authors:  S Maeda; Y Kagami; M Ogura; H Taji; R Suzuki; E Kondo; S Asakura; T Takeuchi; K Miura; M Ando; S Nakamura; T Ito; T Kinoshita; R Ueda; Y Morishima
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

Review 2.  Graft-versus-host disease of the intestine.

Authors:  G J Cox; G B McDonald
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Lymphocyte populations in autopsy bone marrow sections from recipients of allogeneic marrow and non-transplant sudden death cases.

Authors:  S A Dilly; C J Jagger; J P Sloane
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

Review 4.  Mixed hematopoietic chimerism and transplantation tolerance.

Authors:  B Nikolic; M Sykes
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

5.  Complete sequential regeneration of graft-vs.-host-induced severely dysplastic thymuses. Implications for the pathogenesis of chronic graft-vs.-host disease.

Authors:  T Ghayur; T A Seemayer; A Xenocostas; W S Lapp
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

6.  Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation.

Authors:  J S Song; W B London; E B Hawryluk; D Guo; M Sridharan; D E Fisher; L E Lehmann; C N Duncan; J T Huang
Journal:  Bone Marrow Transplant       Date:  2017-04-03       Impact factor: 5.483

7.  White pulp reconstitution after human bone marrow transplantation.

Authors:  A Nakayama; N Hirabayashi; M Ito; K Kasai; M Fujino; M Ohbayashi; J Asai
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

8.  Leptin selectively augments thymopoiesis in leptin deficiency and lipopolysaccharide-induced thymic atrophy.

Authors:  Ryan W Hick; Amanda L Gruver; Melissa S Ventevogel; Barton F Haynes; Gregory D Sempowski
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

9.  Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses.

Authors:  Matthew J Billard; Amanda L Gruver; Gregory D Sempowski
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

10.  Alterations of thymus cortical epithelium and interdigitating dendritic cells but no increase of thymocyte cell death in the early course of simian immunodeficiency virus infection.

Authors:  J G Müller; V Krenn; C Schindler; S Czub; C Stahl-Hennig; C Coulibaly; G Hunsmann; C Kneitz; T Kerkau; A Rethwilm
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.